Acadia Pharmaceuticals (ACAD) Q2 2022 Earnings

4MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.67
-0.48
-0.28
-0.09

Details

Expected EPS
-0.67
Actual EPS
-0.33
Surprise EPS
0.34
Surprise Percent
+50.75%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.33 per share for Q2 2022.

0 Comments

Share your thoughts